Healthcare

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) reported that its Phase 3 LUGANO trial for DURAVYU in wet age-related macular degeneration missed the primary best-corrected visual acuity endpoint in the full dataset.

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) has compressed a year of corporate news into five weeks: positive mid-stage clinical data, a formal search for a partner to fund the expensive part, and quarterly accounts showing how little time it has to close that deal.

Tenon Medical, Inc. (NASDAQ:TNON) makes implants that fuse the sacroiliac joint, the load-bearing hinge where the base of the spine meets the pelvis and an under-diagnosed source of chronic lower-back pain. The Los Gatos, California company has spent six weeks growing sales faster than …

Reviva Pharmaceuticals Holdings, Inc. (OTCQB:RVPH) is a Cupertino, California clinical-stage drug developer whoseInvestmentcase rests almost entirely on one molecule: brilaroxazine, an experimental once-daily pill for schizophrenia.

IceCure Medical Ltd. (NASDAQ:ICCM), the Israeli developer of the ProSense liquid-nitrogen cryoablation system, is trying to prove a hard-won U.S. clearance can turn into revenue. On 12 August 2026 it reported first-half sales up about 45% year over year, its strongest growth since the …

Intensity Therapeutics, Inc. (NASDAQ:INTS) spent much of the past 18 months with both of its lead cancer studies standing still. One was halted for money, the other for safety. In July it began dosing patients again in the smaller of the two, and on …

Moleculin Biotech, Inc. (NASDAQ:MBRX) did two things on the same July morning that small drug developers usually do months apart: it released a fresh interim look at the most important trial it has ever run, and priced a stock sale to help pay for …